tert-butyl 4-({[1-(4-fluorophenyl)cyclobutyl]methyl}carbamoyl)piperidine-1-carboxylate | 1338349-01-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: tert-butyl 4-({[1-(4-fluorophenyl)cyclobutyl]methyl}carbamoyl)piperidine-1-carboxylate
• 英文别名: tert-butyl 4-[[1-(4-fluorophenyl)cyclobutyl]methylcarbamoyl]piperidine-1-carboxylate
• CAS: 1338349-01-1
• 化学式: C₂₂H₃₁FN₂O₃
• 分子量: 390.498
• InChiKey: SVLGXTFUTCCZFO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.01
• 重原子数：
  28.0
• 可旋转键数：
  4.0
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.64
• 拓扑面积：
  58.64
• 氢给体数：
  1.0
• 氢受体数：
  3.0

反应信息

• 作为反应物：
  描述：

  tert-butyl 4-({[1-(4-fluorophenyl)cyclobutyl]methyl}carbamoyl)piperidine-1-carboxylate 在 盐酸 、 sodium acetate 、 三乙酰氧基硼氢化钠 作用下， 以 二氯甲烷 、 乙酸乙酯 为溶剂， 反应 33.0h， 生成 1-benzyl-N-{[1-(4-fluorophenyl)cyclobutyl]methyl}piperidine-4-carboxamide hydrochloride
  参考文献：
  名称：

  Synthesis and pharmacological evaluation of 1-alkyl-N-[2-ethyl-2-(4-fluorophenyl)butyl]piperidine-4-carboxamide derivatives as novel antihypertensive agents

  摘要：

  We synthesized and evaluated inhibitory activity against T-type Ca(2+) channels for a series of 1-alkyl-N-[2-ethyl-2-(4-fluorophenyl)butyl]piperidine-4-carboxamide derivatives. Structure-activity relationship studies have revealed that dialkyl substituents at the benzylic position play an important role in increasing inhibitory activity. Oral administration of N-[2-ethyl-2-(4-fluorophenyl)butyl]-1-(2-phenylethyl)piperidine-4-carboxamide (20d) lowered blood pressure in spontaneously hypertensive rats without inducing reflex tachycardia, which is often caused by traditional L-type Ca(2+) channel blockers. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2011.07.030
• 作为产物：
  描述：

  对氟苯乙腈 在 ammonium hydroxide 、 氢气 、 sodium hydride 、 1-羟基苯并三唑 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 作用下， 以 乙醇 、 N,N-二甲基甲酰胺 、 mineral oil 为溶剂， 反应 52.0h， 生成 tert-butyl 4-({[1-(4-fluorophenyl)cyclobutyl]methyl}carbamoyl)piperidine-1-carboxylate
  参考文献：
  名称：

  Synthesis and pharmacological evaluation of 1-alkyl-N-[2-ethyl-2-(4-fluorophenyl)butyl]piperidine-4-carboxamide derivatives as novel antihypertensive agents

  摘要：

  We synthesized and evaluated inhibitory activity against T-type Ca(2+) channels for a series of 1-alkyl-N-[2-ethyl-2-(4-fluorophenyl)butyl]piperidine-4-carboxamide derivatives. Structure-activity relationship studies have revealed that dialkyl substituents at the benzylic position play an important role in increasing inhibitory activity. Oral administration of N-[2-ethyl-2-(4-fluorophenyl)butyl]-1-(2-phenylethyl)piperidine-4-carboxamide (20d) lowered blood pressure in spontaneously hypertensive rats without inducing reflex tachycardia, which is often caused by traditional L-type Ca(2+) channel blockers. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2011.07.030

文献信息

• Synthesis and pharmacological evaluation of 1-alkyl-N-[2-ethyl-2-(4-fluorophenyl)butyl]piperidine-4-carboxamide derivatives as novel antihypertensive agents
  作者：Susumu Watanuki、Keisuke Matsuura、Yuichi Tomura、Minoru Okada、Toshio Okazaki、Mitsuaki Ohta、Shin-ichi Tsukamoto

  DOI：10.1016/j.bmc.2011.07.030

  日期：2011.9

  We synthesized and evaluated inhibitory activity against T-type Ca(2+) channels for a series of 1-alkyl-N-[2-ethyl-2-(4-fluorophenyl)butyl]piperidine-4-carboxamide derivatives. Structure-activity relationship studies have revealed that dialkyl substituents at the benzylic position play an important role in increasing inhibitory activity. Oral administration of N-[2-ethyl-2-(4-fluorophenyl)butyl]-1-(2-phenylethyl)piperidine-4-carboxamide (20d) lowered blood pressure in spontaneously hypertensive rats without inducing reflex tachycardia, which is often caused by traditional L-type Ca(2+) channel blockers. (C) 2011 Elsevier Ltd. All rights reserved.